Skip to content
Epomedicine

Mnemonics, Simplified Concepts & Thoughts

Epomedicine

Mnemonics, Simplified Concepts & Thoughts

multiple myeloma features

Multiple Myeloma : Quick Approach

Epomedicine, Mar 7, 2016Jun 12, 2016

Plasma cell dyscrasia refers to an abnormal proliferation of plasma cells that usually secrete a monoclonal immunoglobulin.

A) CLINICAL FEATURES

Features vary among various conditions:

Mnemonic: CRAB Infection

1. Calcium increased:

  • Hypercalcemia
  • Nephrocalcinosis

and

Coagulopathy: Inhibition of or antibody against clotting factor; antibody-coated platelets

2. Renal failure or Renal Tubular Acidosis type II: Causes include –

  • Bence-Jones Proteinuria
  • Nephrocalcinosis
  • Amyloidosis
  • Hyperuricemia
  • UTI
  • Infiltration by myeloma cells

3. Anemia, Leukopenia, Thrombocytopenia

and

Amyloidosis

4. Bone:

  • Swelling
  • Pain
  • Compression myelopathy
    • POEMS syndrome: Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, Skin changes

5. Infections: due to hypogammaglobulinemia

6. Hyperviscosity:

  • Blurring of vision
  • Headache
  • Vertigo
  • Nystagmus

6. Other: Peripheral neuropathy, Myelomatous meningitis

B) INVESTIGATIONS

multiple myeloma features

  • CBC: Pancytopenia, Increased ESR
  • PBS: Rouleax formation
  • Biochemistry profile:
    • ↑ Calcium
    • ↑ Urate
    • Deranged RFT
    • Electrolytes
    • ALP ↑/=
    • ↓ Protein; ↑ Albumin and ↓ Globulin
  • Serum protein electrophoresis (SPEP): Quantifies M-protein (positive in 80%)
  • Urine protein electrophoresis (UPEP): Detects 20% patients who are light chain secretors (BJ proteins)
  • Immunofixation: Shows component is monoclonal and identifies immunoglobulin type –
    • IgG (50%) > IgA (20%) > IgD (2%) > IgM (0.5%)
    • Light chain only (20%)
    • Non-secretors (1%) – plasma cells cannot excrete immunoglobulin molecule
  • Serum free light chain assay: diagnosis and follow-up of treatment response
  • β2 microglobulin and LDH: tumor burden
  • Bone marrow biopsy:
    • better prognosis = hyperdiploidy
    • worse prognosis = deletion of chromosome 17p13 (10%) and certain translocations
  • Skeletal survey: Plain radiographs to identify lytic bone lesions and pathological fractures; bone scan is not useful in diagnosing lytic lesions

C) DIAGNOSTIC CRITERIA OF MULTIPLE MYELOMA

International Myeloma working group Diagnostic criteria: ≥2 of –

1. Asymptomatic:

  • M-protein ≥ 3 gm/dl and/or
  • Bone-marrow plasma cells ≥ 10%

2. Symptomatic: + ≥1 of CRAB

  • Corrected Calcium ≥ 11.5 mg/dl
  • Renal failure (Creatinine > 2 mg/dl)
  • Anemia (Hb < 10 gm/dl)
  • Bone (multiple lytic lesions/osteopenic)

D) VARIANTS

  • 1 bone lesion, normal bone marrow, normal uninvolved immunoglobulins: biopsy shows solitary plasmacytoma
  • Soft tissue mass (Upper respiratory tract, GI), No bone lesion, Normal bone marrow: Biopsy shows Extramedullary plasmacytoma
  • No CRAB: Asymptomatic/Smoldering multiple myeloma
  • Normal CBC and chemistries, Bone marrow ≤ 10% plasma cells, No lytic lesions, M component < 3 gm/dl, Normal uninvolved Immunoglobulins, Often normal UPEP: Monocloncal Gammopathy of Undetermined Significance (MGUS)
  • Waldenstorm Macroglobulinemia:
    • lymphoplasmacytic lymphoma (B-cell neoplasm secreting monoclonal IgM)
    • like MGUS – no evidence of lytic bone lesions
    • Fatigue (anemia)
    • Tumor infiltration: bone marrow (cytopenia), hepatomegaly, splenomegaly
    • Circulating monoclonal IgM: hyperviscosity, type I cryoglobulinemia (Raynaud’s phenomenon), platelet dysfunction (mucosal bleeding)
    • IgM deposition: Amyloidosis, Glomerulopathy
    • Autoantibody activity of IgM: chronic AIHA, neuropathy (IgM against myelin-associated glycoprotein)

E) STAGING

multiple myeloma staging

Durie Salmon staging mnemonic: ABCdE

  1. Anemia: >10 to <8.5
  2. Bony lesions: <2 to Advanced
  3. BJ proteins (urine light chain): <4 gm/24 hr to >12 gm/24 hr
  4. Calcium degree: <12 to >12
  5. Electrophoresis:
    • IgG: <5 to >7
    • IgA: <3 to >5

F) TREATMENT

1. General treatment:

myeloma general treatment

Plasmapheresis for hyperviscosity

2. Specific treatment:

a. Multiple myeloma: Chemotherapy ± Radiotherapy (for local problems) ± Autologous stem cell transplant (in <65 years without renal failure)

  • Chemotherapy:
    • Mephalan + Prednisolone X 6 wk pulses
    • If cytopenic: IV cyclophosphamide weekly
    • Fail/relapse: VAD (Vincristine, Adriamycin, Dexamethasone)
    • Newer drugs: Thalidomide, Lenalidomide, Bortezomib

b. Solitary plasmacytoma: Radiotherapy <45 Gy; F/U with SPEP, IEP and UPEP

c. Extramedullary plasmacytoma: Radiotherapy

d. Asymptomatic/Smoldering multiple myeloma:

  • Low risk features: Follow Up
  • High risk features: Follow Up by Observation vs Chemotherapy

e. MGUS: Follow up with SPEP in 6 months and then yearly

f. Waldenstorm’s macroglobulinemia:

  • Oral alkylating agents
  • Newer therapies: Nucleoside analogs (fludarabine, cladribine), monoclonal antibodies (anti-CD20), thalidomide
  • High dose chemotherapy followed by stem cell transplant for younger patients
21 shares
  • Facebook21
  • Twitter
PGMEE, MRCS, USMLE, MBBS, MD/MS Cardiovascular systemInternal medicinePediatrics

Post navigation

Previous post
Next post

Related Posts

PGMEE, MRCS, USMLE, MBBS, MD/MS groin hernia

Hernia – Inguinal Hernia

Apr 23, 2020May 20, 2020

Groin is the area between abdomen and the upper thigh on either sides of pubic symphysis. Protrusions of the abdominal contents through the weak areas in this region are grouped under groin hernias. Groin Hernia can be classified into Inguinal and Femoral Hernias. Please go though another article of the…

Read More
PGMEE, MRCS, USMLE, MBBS, MD/MS fetal skull transverse

Fetal Skull Dimensions : Mnemonic

Jul 27, 2018

Anteroposterior Diameters Mnemonic: Larger the alphabets, larger the diameter (V>F>B) Diameters with “sub” prefix are smaller than counterpart without it. mento-Vertical: 14 cm SUB-mento-Vertical: 11.5 cm occipito-Frontal: 11.5 cm SUB-occipito-Frontal: 10.5 cm sub-occipito-Bregmatic: 9.5 cm sub-mento-Bregmatic: 9.5 cm Transverse Diameters Mnemonic: MTP (Medical Termination of Pregnancy) in increasing order. bi-Mastoid:…

Read More
PGMEE, MRCS, USMLE, MBBS, MD/MS

Meckel’s Diverticulum : Rule of 2

Sep 7, 2023Sep 7, 2023

General description Rule of 2s 1. Occurs in 2% population 2. Symptomatic cases are 2 times more common in males 3. Located within 2 feet proximal to ileocecal valve 4. 2 inches long and 2 cm diameter 5. 2 types of ectopic mucosa: gastric and pancreatic 6. Symptomatic only in…

Read More

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Epomedicine. Multiple Myeloma : Quick Approach [Internet]. Epomedicine; 2016 Mar 7 [cited 2026 Nov 19]. Available from: https://epomedicine.com/medical-students/hemolytic-anemia-quick-approach/.

Pre-clinical (Basic Sciences)

Anatomy

Biochemistry

Community medicine (PSM)

Embryology

Microbiology

Pathology

Pharmacology

Physiology

Clinical Sciences

Anesthesia

Dermatology

Emergency medicine

Forensic

Internal medicine

Gynecology & Obstetrics

Oncology

Ophthalmology

Orthopedics

Otorhinolaryngology (ENT)

Pediatrics

Psychiatry

Radiology

Surgery

RSS feed: Ask Epomedicine Ask Epomedicine

  • What to study for Clinical examination in Orthopedics?
  • What is the mechanism of AVNRT?

Epomedicine weekly

  • About Epomedicine
  • Contact Us
  • Author Guidelines
  • Submit Article
  • Editorial Board
  • USMLE
  • MRCS
  • Thesis
©2026 Epomedicine | WordPress Theme by SuperbThemes